- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04600869
Effects of Naturalistic Decision-Making Model-based Oncofertility Care Education
Effects of Naturalistic Decision-Making Model-based Oncofertility Care Education for Nurses and Patients With Breast Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Nurses play an essential role in transferring knowledge to patients. However, several factors cause nurses to adopt a negative attitude toward providing oncofertility care.
Objective: This study examined the effects of an oncofertility education program on decisional conflict in nurses caring for breast cancer patients and patients with breast cancer. Other predictors of decisional conflict were also examined.
Design: Randomized, controlled experimental research. Settings and Participants: Patients (61) with breast cancer and nurses (79) were recruited from a hospital in Taipei, Taiwan.
Methods: The nursing participants were randomly assigned to receive oncofertility education (experimental group) or usual education (control group). Data from female patients in the control and experimental groups were collected before and after the nurses' educational training, respectively. The oncofertility education consisted of one face-to-face educational session and reading one educational booklet based on the Naturalistic Decision-Making (NDM) Model. The decisional conflict was measured using the Chinese version of the decisional conflict scale.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
New Taipei City, Taiwan
- Department of Nursing
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All nurses involved in breast care were recruited into the study.
- Female patients with breast cancer who were younger than 50 years and who were about to start cancer treatment were recruited from one teaching hospital in Taipei, Taiwan.
Exclusion Criteria:
- Women with a major illness or mental disorder before their cancer diagnosis were excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nursing Group
Nurses in the control group accepted the other non-fertility (standard) nursing training for the intervention, whereas those in the experimental group accepted the oncofertility training.
Based on research ethics and design, a standard education course was held for the control group after completing data collection in the nursing experimental group.
We began to recruit patients into the patient experimental group after all nurses completed their educational courses.
|
We designed the education program according to Klein's NDM model, which explored the reasoning mechanism behind decision-making (Klein, 1993).
It depends on the on-the-job training date in each unit.
The education program consisted of the following: (1) Information accumulation: explanations of common cancer therapies related to subsequent infertility, psychological and mental change in cancer survivors with infertility, the necessity and method of early determination of fertility intention, and type of fertility preservation.
(2) Sense-making: situational case sharing, emphasis on the guidance interaction between experienced and novice nurses to understand the patient's situation.
(3) Decision-making: how to provide support, how to correspond, and attitudes toward people with strong fertility intention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Decisional conflict
Time Frame: Nurses: 1 month; Patients: 6 months
|
The decisional conflict was measured using the Chinese version of the decisional conflict scale.
Each item was rated on a five-point Likert scale, ranging from zero to 4. The score was calculated by averaging the sum of individual item scores, then multiplying the product by 25.
Hence, the scores range from 0 to 100.
A higher score indicates higher decisional conflict.
Both nursing and patient participants were asked to fill out the questionnaire.
|
Nurses: 1 month; Patients: 6 months
|
|
Oncofertility Barrier Scale
Time Frame: Nurses: 1 month
|
An Oncofertility Barrier Scale was developed to assess nurses' perceptions of comprehensive barriers regarding oncofertility care.
The responses to each item were provided using a five-point Likert scale.
A higher scale score meant the nurses perceived that it was more difficult to provide oncofertility care.
|
Nurses: 1 month
|
|
Infertility Knowledge Questionnaire
Time Frame: Nurses: 1 month; Patients: 6 months
|
We used the Infertility Knowledge Questionnaire to measure both of nurses' and patients' knowledge of infertility in patients with breast cancer.
Total scores for the 11 items ranged from zero to 11. Centimeters were used to show the ratio of correct answers visually.
A higher score meant a greater level of knowledge about infertility.
Both nursing and patient participants were asked to fill out the questionnaire.
|
Nurses: 1 month; Patients: 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fertility Intention Scale
Time Frame: Patients: 6 months
|
The Fertility Intention Scale with 15 items was used to measure patients' fertility intentions.
The standardized scale ranged from 1 to 5 points on a five-point Likert scale.
Higher scores indicated a greater degree of fertility intention.
|
Patients: 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sheng-Miauh Huang, PhD, Department of Nursing, Mackay Medical College
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSM/VGH-2017-01-011AC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Naturalistic Decision-Making Model-based Oncofertility Care Education
-
West China HospitalRecruitingCarcinoma, Non-Small-Cell Lung | Lung Neoplasms | Small Cell Lung Carcinoma | ElderlyChina
-
Seoul National University HospitalAsan Medical Center; Chonnam National University Hospital; Korea University Guro... and other collaboratorsRecruitingADPKD (autosomal Dominant Polycystic Kidney Disease)Korea, Republic of
-
Necmettin Erbakan UniversityNot yet recruitingMobile Applications | Ethical Sensitivity | Ethical Decision-making
-
Ain Shams UniversityCompleted
-
Wake Forest University Health SciencesCompleted
-
United States Department of DefenseMayo Clinic; Baylor College of Medicine; Minneapolis Veterans Affairs Medical... and other collaboratorsRecruitingPost Traumatic Stress DisorderUnited States
-
Milton S. Hershey Medical CenterAmerican Cancer Society, Inc.Completed
-
Public Health Foundation of IndiaLondon School of Hygiene and Tropical Medicine; Bill and Melinda Gates Foundation and other collaboratorsActive, not recruitingAnemia | Gestational Diabetes Mellitus (GDM) | Pregnancy Induced Hypertension (PIH)India, Nepal
-
Ying WangCompletedCritical Illness | Pregnant WomenChina
-
Second Affiliated Hospital of Nanchang UniversityFirst Affiliated Hospital of Zhejiang University; Renmin Hospital of Wuhan... and other collaboratorsRecruitingHemorrhage StrokeChina